Home -> Law Blog Directory -> International Law Blogs -> Australian Regulatory Compliance Review
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
International Law
: Australian Regulatory Compliance ReviewUpdated guidance from Takeovers Panel
By Patrick Dwyer
Australia’s Takeovers Panel has released the following updated Guidance Notes:
- Guidance Note 7: Lock-Up Devices
- Guidance Note 12: Frustrating Action
- Guidance Note 14: Funding Arrangements
- Guidance Note 17: Rights Issues
Copies are available at www.takeovers.gov.au
The Panel identified the following key changes and clarifications in the Guidance Notes:
Guidance Note 7: Lock-Up Devices
- The guidance note applies to any control transaction.
- Triggers for payment of break fees must be reasonable.
- There is clarification of the 1% guideline for break fees.
- Re-writing of the section on restriction agreements.
Guidance Note 12: Frustrating Action
- Shareholders may be given a choice between proposals in different ways.
- Where a target can get shareholder approval of a frustrating action by directors announcing they will enter into an agreement after a specified, reasonable time (unless control has by then passed to the bidder), ‘reasonable time’ may be affected by the length of the bid period or the status of any bid conditions.
- Additional examples.
Guidance Note 14: Funding Arrangements
- Reduced internal-cross referencing.
- Bringing related subjects together.
Guidance Note 17: Rights Issues
- Updated references.
- Removal of concepts of presumption and onus.
- Sets out factors that are relevant to the Panel’s consideration of unacceptable circumstances.
Full post as published by Australian Regulatory Compliance Review on February 13, 2010 (boomark / email).
Darvocet
FDA Expert Panel Votes for Ban
Insignia
26-Inch Flat-Panel LCD TVs Recalled
Gulf War Syndrome
Panel Confirms it's Real, and Identifies Causes
Pull Vicodin, Percocet
Expert Panel Advises FDA

Some Guidance on Corp Fin's Updated 13e-3 Interps
OMB Publishes Updated Guidance for Implementing ARRA
ICO guidance on vexatious requests updated
Corp Fin Issues Updated Section 16 and Form 8-K Guidance
SEC Adopts New "Corporate Use of Website" Guidance
Updated ICO Freedom of Information guidance








